Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion type Assertion NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_head.
- NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion description "[In most lung cancers, this resistance is associated with the overexpression of (a) multidrug resistance-associated protein (MRP) responsible for drug efflux from the cancer cells (pump resistance) and (b) BCL2 protein that activates antiapoptotic cellular defense (nonpump resistance).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_provenance.
- NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion evidence source_evidence_literature NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_provenance.
- NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion SIO_000772 15342407 NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_provenance.
- NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion wasDerivedFrom befree-2016 NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_provenance.
- NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_assertion wasGeneratedBy ECO_0000203 NP458350.RAEzP2f2uDO9LRSY-y5W5XtIrLyMrxeZ6E40EECcZcxbs130_provenance.